Current management of atrial fibrillation in routine practice according to the last ESC guidelines: an EHRA physician survey-how are we dealing with controversial approaches?

导出 OA

翻译打印收藏纠错

作者： Jose M,Guerra ^[1] ; Zoraida,Moreno Weidmann ^[1] ; Laura,Perrotta ^[2] ; Arian,Sultan ^[3] ; Ante,Anic ^[4] ; Andreas,Metzner ^[5] ; Rui,Providencia ^[6] ; Serge,Boveda ^[7] ; Julian,Chun ^[8]

作者单位： Department of Cardiology, Hospital de la Santa Creu i Sant Pau, IR SANT PAU, Universitat Autònoma de Barcelona, CIBERCV, Sant Antoni M. Claret 167, 08025 Barcelona, Spain. ^[1] Arrhythmia Unit, Careggi University Hospital, Florence, Italy. ^[2] Department of Electrophysiology, Heart Center, University of Cologne, Köln, Germany. ^[3] Department for Cardiovascular Diseases, University Hospital Centre, Split, Croatia. ^[4] Department of Cardiology, University Heart and Vascular Center Hamburg, University Hospital Hamburg-Eppendorf, Hamburg, Germany. ^[5] Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, London, UK. ^[6] Institute of Health Informatics Research, University College London, London, UK. ^[7] Department of Cardiology, Heart Rhythm Management, Clinique Pasteur, Toulouse, France. ^[8] Brussels University VUB, Brussels, Belgium. ^[9] Cardioangiologisches Centrum Bethanien (CCB), Medizinische Klinik III, Agaplesion Markus Krankenhaus, Frankfurt am Main, Germany. ^[10]

关键词 Ablation Antiarrhythmic treatment Anticoagulation Atrial fibrillation Clinical practice Comorbidities Guidelines

主题词人类(Humans);心房颤动(Atrial Fibrillation);共病现象(Comorbidity);索他洛尔(Sotalol);抗凝药(Anticoagulants);治疗结果(Treatment Outcome)

DOI 10.1093/europace/euae012

PMID 38227804

发布时间 2024-02-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交